Working with its clients to ensure a successful outcome in terms of market access, Grove consultants based in Poland provide expert advice in three key areas:
The Polish healthcare sector is relatively well developed and organized in comparison to others within the Central and Eastern European region. Regulatory systems are transparent and predictable. Logistics are relatively easy and continuing to improve.
Corruption is minimal. Although the introduction of a rigorous reimbursement system in 2012 halved the pharmaceutical market value, the sector has since recovered, and the reimbursement system has served to increase compliance and access to pharmaceuticals within a system where healthcare is universally available.
As in other areas, the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products and the Ministry of Health play a key role in the market for medicines, medical devices, food supplements and cosmetics.
The relatively transparent and predictable local regulatory procedures still require careful navigation. Only with an understanding of the Polish reimbursement policy, can new market entrants hope to get their own price and reimbursement strategies and subsequent reimbursement application right. With experienced local consultants, Grove can assist with: